ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a…
Insider buying and selling since 2011
ORBIMED ADVISORS LLC bought shares on the open market in 12 different years since 2011 across 31 companies. Sales in each of the last 3 years.
ORBIMED ADVISORS LLC reported 77 open-market purchases and 168 sales since 2011; purchases in 12 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 1×1 trade | — |
| 2025 | 9×9 trades | 49×49 trades |
| 2024 | 4×4 trades | 17×17 trades |
| 2023 | 9×9 trades | 12×12 trades |
| 2022 | 5×5 trades | — |
| 2021 | 5×5 trades | 8×8 trades |
| 2020 | 6×6 trades | 28×28 trades |
| 2019 | 7×7 trades | 22×22 trades |
| 2018 | 13×13 trades | 16×16 trades |
| 2017 | 3×3 trades | — |
| 2016 | 11×11 trades | 6×6 trades |
| 2012 | — | 2×2 trades |
| 2011 | 4×4 trades | 8×8 trades |
Insider at 31 companies
- Traws Pharma TRAW2026 · 1 purchase, 0 sales
- Disc Medicine IRON2023–2025 · 3 purchases, 27 sales
- Passage Bio PASG2022–2025 · 3 purchases, 22 sales
- Corvus Pharmaceuticals CRVS2016–2025 · 14 purchases, 1 sale
- Neuropace NPCE2024–2025 · 0 purchases, 9 sales
- Mbx Biosciences MBX2024–2025 · 6 purchases, 0 sales
- Compass Therapeutics CMPX2020–2025 · 5 purchases, 1 sale
- Xtant Medical Holdings XTNT2018–2025 · 2 purchases, 2 sales
- Edgewise Therapeutics EWTX2021–2025 · 4 purchases, 0 sales
- Pmv Pharmaceuticals PMVP2020–2025 · 1 purchase, 1 sale
- Shattuck Labs STTK2025 · 2 purchases, 0 sales
- Sionna Therapeutics SION2025 · 1 purchase, 0 sales
- Tela Bio TELA2019–2024 · 1 purchase, 6 sales
- Upstream Bio UPB2024 · 2 purchases, 0 sales
- Damora Therapeutics DMRA2023 · 0 purchases, 9 sales
- Adicet Bio ACET2023 · 4 purchases, 0 sales
- Oric Pharmaceuticals ORIC2020–2021 · 1 purchase, 8 sales
- Janux Therapeutics JANX2021 · 2 purchases, 0 sales
- Alector ALEC2019–2020 · 3 purchases, 36 sales
- Inspire Medical Systems, Inc. INSP2018–2020 · 1 purchase, 14 sales
- Prelude Therapeutics PRLD2020 · 2 purchases, 0 sales
- Calcimedica CALC2020 · 1 purchase, 0 sales
- Glaukos Corp. GKOS2016–2018 · 0 purchases, 20 sales
- Kala Bio KALA2018 · 7 purchases, 0 sales
- Palvella Therapeutics PVLA2018 · 0 purchases, 2 sales
- Whitehawk Therapeutics WHWK2018 · 1 purchase, 0 sales
- Si-Bone SIBN2018 · 1 purchase, 0 sales
- Spyre Therapeutics SYRE2017 · 3 purchases, 0 sales
- Cartesian Therapeutics RNAC2016 · 2 purchases, 0 sales
- Amarin Corp Plc\Uk AMRN2011–2012 · 0 purchases, 10 sales
- Pacira BioSciences, Inc. PCRX2011 · 4 purchases, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about ORBIMED ADVISORS LLC's trades
Has ORBIMED ADVISORS LLC bought shares on the open market?
ORBIMED ADVISORS LLC bought shares on the open market in 12 different years since 2011 across 31 companies. Sales in each of the last 3 years.
When did ORBIMED ADVISORS LLC last buy or sell shares?
In SEC filings since 2011: the latest open-market purchase is from 2026; the latest open-market sale is from 2025.
Which companies has ORBIMED ADVISORS LLC traded as an insider?
31 companies: Traws Pharma (TRAW, 2026), Disc Medicine (IRON, 2023–2025), Passage Bio (PASG, 2022–2025), Corvus Pharmaceuticals (CRVS, 2016–2025), Neuropace (NPCE, 2024–2025) and others.